Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18287
Title: Can molecularly targeted therapy cure patients with resected EGFR mutant NSCLC?
Austin Authors: Klevansky, Myron ;John, Thomas 
Affiliation: Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Victoria, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Issue Date: Jun-2018
Publication information: Journal of thoracic disease 2018; 10(Suppl 17): S1986-S1988
URI: http://ahro.austin.org.au/austinjspui/handle/1/18287
DOI: 10.21037/jtd.2018.04.156
PubMed URL: 30023098
ISSN: 2072-1439
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

4
checked on Nov 29, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.